3-Chloro-1,2-dihydroxypropane


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000072660 Teratozoospermia PMID:35063618
MESH:D001259 Ataxia PMID:33187795
MESH:D001930 Brain Injuries PMID:14644096
MESH:D002493 Central Nervous System Diseases PMID:27017489
MESH:D006332 Cardiomegaly PMID:33187795
MESH:D006335 Heart Injuries PMID:33187795
MESH:D006470 Hemorrhage PMID:14644096
MESH:D006529 Hepatomegaly PMID:33187795
MESH:D007248 Infertility, Male PMID:16472968
MESH:D007674 Kidney Diseases PMID:27017489; PMID:30107153; PMID:33187795; PMID:33651226; PMID:34915118; PMID:35149085
MESH:D007984 Leydig Cell Tumor PMID:26072098
MESH:D009845 Oligospermia PMID:35063618
MESH:D011141 Polyuria PMID:33187795
MESH:D013733 Testicular Diseases PMID:27017489; PMID:33187795; PMID:35063618
MESH:D015431 Weight Loss PMID:33187795; PMID:35063618
MESH:D019457 Chromosome Breakage PMID:28070108
MESH:D053627 Asthenozoospermia PMID:20409345
MESH:D055371 Acute Lung Injury PMID:33187795
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:33187795
MESH:D058186 Acute Kidney Injury PMID:29860048; PMID:38373586

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.